Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa francesa ofrece un dispositivo de administración oral de medicamentos con software de atención a distancia para seguimiento de pacientes en el hogar

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOFR20190919001
Publicado:
30/09/2019
Caducidad:
30/09/2020
Resumen:
Una empresa francesa del sector de eSalud ofrece una solución integral que combina un dispositivo de administración oral de medicamentos y un software de atención a distancia para seguimiento de pacientes en el hogar. Esta solución monitoriza y suministra medicamentos orales en el hogar de forma segura y está asociada con un software de asistencia a distancia que permite compartir datos y resultados informados por el paciente con profesionales sanitarios. La solución puede adaptarse a cualquier enfermedad tratada con medicamentos orales en la población de pacientes con riesgo que necesiten un control riguroso. Actualmente se están realizando experimentos en oncología con dos pacientes de Francia y en nefrología en insuficiencia renal en una red de atención sanitaria francesa. La empresa busca pymes, instituciones sanitarias o compañías farmacéuticas con el fin de establecer acuerdos de cooperación técnica o comercialización.

Details

Tittle:
French company offers connected oral drug delivery device with remote-care software for follow-up of patients at home
Summary:
French e-Health company offers a global solution gathering a connected oral drug delivery device and a remote-care software for the follow-up of patients at home. The solution monitors and delivers at home oral drugs in a secure way and is associated with a remote-care software allowing to share data and patient-reported outcomes with healthcare professionnals. The company is seeking technical cooperations or commercial agreements with other SMEs, healthcare institutions or pharma companies.
Description:
To meet the challenge of the increase of chronic diseases, the increase of elderly patient population and the sustainability of the healthcare system, it appears that ambulatory/home cares development and oral drugs administration at home for the treatment and the management of serious diseases are the major orientation of healthcare system worldwide.
In this situation, patient and healthcare professionnals (hospital sector and ambulatory sector) need an efficient information system for an optimal organisation of cares and for an appropriate patients follow-up, checking adherence to the treatment and early alerting of adverse events or complications. In addition, oral drugs for treating serious diseases are more and more available for prescriptions by healthcare professionnals. These oral drugs are complex in terms of scheme of administration and need a close monitoring for adverse event prevention or management.
To cover this need and meet such evolution, the development is on-going for a patient-centric digital solution integrating a connected device. This solution monitors and delivers at home oral drugs in a secure way. It is associated with a remote-care software which shares clinical data, biological data, treatment data and patient-reported outcomes between all healthcare professionnals and the patient.
The application of the offer could be tailored for any diseases treated with oral drugs in at risk patients population who need scrutiny.
At the moment, experiments are led in oncology in 2 centers in France and in nephrology in renal failure in one care-network in France. The patient-centered approaches applied to the development of the remote-care software are positive for the patients and are communicated in a poster during a conference in psycho-oncology in November 2019.
The offer is adaptable: it could be the connected device alone associated with a remote-care software developed by a partner or our remote-care software alone for the digital coordination of cares and patients reported outcomes (treatment adherence included) or both of them.

The partnership could be with:
- healthcare institutions which have the project to implement digital organisation of cares,
- others SMEs which want to integrate remote-care sofware technologie or connected device with their apps to monitor adherence to drug and surveillance of patients,
- pharma companies in the frame of their randomized clinical trials or of their study in real life conditions.

The company is interested in technical cooperation agreement, research cooperation agreement or commercial agreement with technical assistance.
Advantages and Innovations:
The offered digital and connected solutions meet these unmet needs and trends.

Advantages of such digital and connected solutions :
- interoperable with the healthcare network and with any connected devices,
- tailored to any diseases which necessitate treatment with oral drug with real time dose adjustment in a secure way,
- it would impact on the organisation of healthcare system hospital and ambulatory care,
- it would bring relevance of care with a better allocation of healthcare resources utilisation for the most demanding patients population,
- it would bring quality of care by preventing / mitigating adverse events or complications,
- it would bring equity in terms of access of care,
- it would improve outcomes and quality of life of patients and helpers,
- it would improve adherence to the treatment, enhance security, limit the wastage of expensive oral drugs and reduce costs of care,
- it would avoid non-relevant sanitary transportation and sparing costs/time associated.
Stage of Development:
Available for demonstration
IPs:
Patents granted,Exclusive Rights

Partner sought

Type and Role of Partner Sought:
The company is looking for partners to implement the proposed digital and connected solutions in response to unmet needs.

The partnership could have the objective to generate more evidence to demonstrate the value of the solution by extension to others diseases and others patients population of interest.

Three types of partners can be sought :
- healthcare institutions (hospitals, care-network, public, private, associations) which has the project to implement digital organisation of cares,
- others SMEs which want to integrate remote-care sofware technologie or connected device with their apps to monitor adherence to drug and surveillance of patients,
- pharma companies in the frame of their Randomized Clinical Trials in R-Y-D, or of early access for drugs (ATU) or of their study in real life conditions.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
French

Keywords

Technology Keywords:
01004001 Applications for Health
01003006 Computer Software
06005003 Gestión de información sobre salud
01003014 Internet Technologies/Communication (Wireless, Bluetooth)
06001002 Investigaciones clínicas, ensayos